Ionis Pharmaceuticals (NASDAQ:IONS) Upgraded to Strong-Buy at HC Wainwright
HC Wainwright upgraded shares of Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) to a strong-buy rating in a report issued on Monday, Marketbeat reports. The firm currently has $45.00 price target on the stock. A number of other brokerages also recently commented on IONS. Royal Bank of Canada reiterated an “outperform” rating and set a $70.00 […]
HC Wainwright upgraded shares of Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) to a strong-buy rating in a report issued on Monday, Marketbeat reports. The firm currently has $45.00 price target on the stock. A number of other brokerages also recently commented on IONS. Royal Bank of Canada reiterated an “outperform” rating and set a $70.00 […]